Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOTECH Board/Management Information 2016

Jul 12, 2016

9301_rns_2016-07-12_176d6d8f-3602-446e-b706-1367885a9cbe.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

THE BIOTECH GROWTH TRUST PLC - Directorate Change

PR Newswire

London, July 12

12 July 2016

THE BIOTECH GROWTH TRUST PLC

(the “Company”)

Notification of Board Changes

The Company hereby announces that Lord Waldegrave of North Hill has retired as a non-executive Director and Chairman of the Company on 12 July 2016. Mr Andrew Joy has taken over as Chairman of the Company with effect from the same date.

It is further announced that Professor Dame Kay Davies, CBE, has taken over from Mr Joy as the Company’s Senior Independent Director and also as the Chairman of the Remuneration Committee.

There is no further information to be disclosed under Listing Rule 9.6.11R to 9.6.15G.

- ENDS-

For further information please contact:

Mark Pope

Frostrow Capital LLP

020 3 008 4913